Overview

Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Two-part study to assess CTP-656 dosed as a solid oral dosage form versus Kalydeco and multiple-ascending doses of CTP-656 dosed for 7 days.
Phase:
Phase 1
Details
Lead Sponsor:
Concert Pharmaceuticals
Treatments:
Ivacaftor